Dr Leong Swan Swan

Dr Leong Swan Swan is a Senior Medical Oncologist at OncoCare Cancer Centre. Her subspecialty interests are in lung cancer, thyroid cancer, and head & neck cancer. She has more than 30 years of clinical practice.

Dr Leong Swan Swan did her basic Medical studies at the National University of Singapore (NUS) and obtained her Master of Medicine (Internal Medicine) at NUS and Membership of the Royal College of Physicians (United Kingdom) in 1995. She started her training in Medical Oncology in 1995 and was awarded HMDP for further training, with a special focus on Thoracic Oncology under Dr Mark Green at Holling’s Cancer Centre in 1997. In 2000, she obtained Specialist Accreditation in Medical Oncology as well as European Society of Oncology (ESMO) certification.

Prior to joining OncoCare Cancer Centre (Singapore), Dr Leong was serving as Senior Consultant in the Department of Medical Oncology, with experience managing different tumour types including, breast cancer, colorectal cancer, gastric cancer, esophageal cancer, lung cancer, head and neck cancer, thyroid cancer, gynaecological cancers, sarcomas, lymphomas as well as less common cancers like mesothelioma.

She was involved in the various multidisciplinary tumour boards, establishing herself as a key opinion cancer specialist in lung as well as head and neck cancers. She was also a Visiting Consultant at Changi General Hospital. She had served as Director of the Ambulatory Treatment Unit at the National Cancer Centre and as Chairperson of the Code Blue Team. In addition to clinical work, Dr Leong was also actively involved in undergraduate teaching, as a Clinical tutor for medical students, as well as teaching junior staff and nurses. She had also given multiple public lectures.

She is a member of the American Society of Oncology, Singapore Society of Oncology, and the International Association of the Study of Lung Cancer (IASLC), having served in the Bylaws Committee and as Auditor of the Society of Geriatric Oncology. She was also involved with the setting up and running of the Singapore Lung Cancer Consortium.

Her research interests are mainly in the field of lung cancer and, head and neck cancer. She was actively involved in clinical and translational research in many investigator-initiated as well as multi-centre industry-sponsored trials. These included trials that led to the approval of various Targeted Therapy Drugs. She was the principal investigator for more than 10 clinical trials for cancer drug development. She has published widely in both local and International journals, including Journal of Clinical Oncology, Chest, Cancer, and has written book chapters for the staging and treatment of lung cancer. Recognised for her expertise in lung and other cancers, she has been a reviewer for several journals, including Journal of Clinical Oncology, Respirology, and Singapore Medical Journal.

Dr Leong is fluent in English, Mandarin, and Cantonese.